Home > Healthcare > Pharmaceuticals > Vaccines > Meningococcal Vaccines Market
Meningococcal Vaccines Market Share
- Report ID: GMI6586
- Published Date: Aug 2023
- Report Format: PDF
Meningococcal Vaccines Market Share
The prominent players in the global meningococcal vaccines market are
- Sanofi SA
- GlaxoSmithKline plc
- Pfizer Inc.
- Novartis AG
- Nuron Biotech
- Hualan Biological Engineering Inc
- Serum Institute of India Ltd.
- JN International Merck & Co., Inc
- Walwax Biotechnology Co.
These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.
Frequently Asked Questions (FAQ) :
Global market for meningococcal vaccines was valued at USD 4.3 billion in 2023 and is expected to reach USD 7.8 billion by 2032, primarily driven by the rising prevalence of meningitis worldwide.
The conjugate vaccines segment held a major market share of 51.1% in 2022 as these vaccines offer advantages in terms of efficacy, and the breadth of protection they provide against multiple serogroups of Neisseria meningitidis.
In 2022, North American market for meningococcal vaccines held a revenue share of 57% and is anticipated to show considerable growth through 2032, driven by favourable initiatives and aids from governments as well as significant research & development expenditures in the region.
Sanofi SA, GlaxoSmithKline plc, Pfizer Inc., Novartis AG, Nuron Biotech, Hualan Biological Engineering Inc, Serum Institute of India Ltd., JN International Merck & Co., Inc, Walwax Biotechnology Co., and others.
Meningococcal Vaccines Market Scope
×
Get a free sample of
Meningococcal Vaccines Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below